Expanded Access Program to Treat Patients with Previously Treated Metastatic Pancreatic Adenocarcinoma with Daraxonrasib
-
Enrollment
This study is not currently enrolling. -
Associated Conditions
-
Research Area
Colorado Cancer Research -
Location
-
Sponsor
Revolution Medicines